Efficient multicomponent reaction synthesis of the schistosomiasis drug praziquantel

Chemistry - A European Journal

Volumn 16, Issue 41, 2010, Pages 12296-12298

  Cao, Haiping ^a   Liu, Haixia ^a   Dömling, Alexander ^a  

^a UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

drug discovery; isocyanides; multicomponent reactions; Pictet Spengler reaction; Ugi reaction

Indexed keywords

DRUG DISCOVERY; ISOCYANIDES; MULTI-COMPONENT REACTIONS; PICTET-SPENGLER REACTIONS; UGI REACTION;

CYANIDES; REACTION KINETICS;

SYNTHESIS (CHEMICAL);

ANTISCHISTOSOMAL AGENT; PRAZIQUANTEL;

ARTICLE; CHEMICAL STRUCTURE; CHEMISTRY; ECONOMICS; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; SCHISTOSOMIASIS; SYNTHESIS;

MAGNETIC RESONANCE SPECTROSCOPY; MOLECULAR STRUCTURE; PRAZIQUANTEL; SCHISTOSOMIASIS; SCHISTOSOMICIDES;

EID: 78249263817     PISSN: 09476539     EISSN: 15213765     Source Type: Journal    
DOI: 10.1002/chem.201002046     Document Type: Article

References (31)

1. P. Steinmann, J. Keiser, R. Bos, M. Tanner, J. Utzinger, Lancet Infect. Dis. 2006, 6, 411 - 425
2. C. R. Caffrey, Curr. Opin. Chem. Biol. 2007, 11, 433 - 439.
3. A.-L. Chenine, E Shai-Kobiler, L. N. Steele, H. Ong, P. Augostini, R. Song, S. J. Lee, P. Autissier, R. M. Ruprecht, W. E. Secor, PLoS Neglected Trop. Dis. 2008, 2, e 265
4. A. Alalade, S. Leeson, U. Andrady, Gynecolog. Surg. 2009, 6, 177 - 180
5. H. Feldmeier, I. Krantz, G. Poggensee, Int. J. Std. AIDS 1994, 5, 368 - 372
6. E. F. Kjetland, P. D. Ndhlovu, E. Gomo, T. Mduluza, N. Midzi, L. Gwanzura, P. R. Mason, L. Sandvik, H. Friis, S. G. Gundersen, AIDS 2006, 20, 593 - 600.
7. P. J. Hotez, A. Fenwick, E. F. Kjetland, PLoS Neglected Trop. Dis. 2009, 3, e430, DOI:.
8. J. Seubert, R. Pohlke, F. Loebich, Experientia 1977, 33, 1036 - 1037.
9. T. M. Bilharz, Z. wiss. Zool. 1853, 4, 53 - 76
10. T. M. Bilharz, Wien. med. Wochenschr. 1856, 6, 49 - 52, 65-68
11. T. M. Bilharz, Z. kais.-kgl. Ges.rzte Wien 1858, 14, 447 - 448.
12. C. H. King, A. A. Mahmoud, Ann. Intern. Med. 1989, 110, 290 - 296.
13. World Health Organization, WHO Model List of Essential Medicines, 15 th ed., World Health Organization, Geneva, 2007, pp. 1 - 27.
14. Z. B. Tohon, H. B. Mainassara, A. Garba, A. E. Mahamane, E. Bosqué-Oliva, M. L. Ibrahim, J. B. Duchemin, S. Chanteau, P. Boisier, PLoS Neglected Trop. Dis. 2008, 2, e 241
15. Schistosomiasis Control Initiative (SCI),.
16. Z. Shena, B. Hanb, S. R. Wickramasingheb, Desalination 2006, 195, 40 - 50.
17. I. Ugi, C. Steinbrückner, Angew. Chem. 1960, 72, 267 - 268
18. S. Marcaccini, T. Torroba, Nat. Protoc. 2007, 2, 632.
19. J. H. Kim, Y. S. Lee, H. Park, C. S. Kim, Tetrahedron 1998, 54, 7395 - 7400
20. J. H. Kim, Y. S. Lee, H. Park, C. S. Kim, Heterocycles 1998, 48, 2278 - 2285.
21. I. Ugi, I. R. Meyr, Angew.Chem. 1958, 70, 702
22. A. W. Hofmann, Justus Liebigs Ann. Chem. 1867, 144, 114
23. W. P. Weber, G. W. Gokel, I. Ugi, Angew. Chem. 1972, 84, 587 - 587
24. Angew. Chem. Int. Ed. Engl. 1972, 11, 530 - 531
25. A. A. Grolla, V. Podesta, M. G. Chini, S. Di Micco, A. Vallario, A. A. Genazzani, P. L. Canonico, G. Bifulco, G. C. Tron, G. Sorba, T. Pirali, J. Med. Chem. 2009, 52, 2776 - 2785.
26. S.-C. Lee, S.-Y. Choi, Y.-K. Chung, S.-B. Park, Tetrahedron Lett. 2006, 47, 6843 - 6847.
27. N. B. Kabatereine, S. Brooker, A. Koukounari, F. Kazibwe, E. Tukahebwa, F. Fleming, Y. Zhang, J. P. Webster, J. R. Stothard, A. Fenwick, Bull. W. H. O. 2007, 85, 91 - 99
28. Y. Zhang, A. Koukounari, N. Kabatereine, F. Fleming, F. Kazibwe, E. Tukahebwa, J. R. Stothard, J. P. Webster, A. Fenwick, BMC Med. 2007, DOI:.
29. Based on 200 million schistosomiasis-infected people and a twice-yearly administration of a 600 mg dose PZQ a need of 120 yato or more active ingredient can be calculated (not included preventative AIDS control).
30. M. W. F. Berkowitz, T. V. John, J. Org. Chem. 1984, 49, 5269 - 5271.
31. M. H. Todd, C. O. Ndubaku, P. A. Bartlett, J. Org. Chem. 2002, 67, 3985 - 3988.